Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease

1 Jul 2019

Abstract excerpt

OBJECTIVE: To determine the key inflammatory pathways that are activated in the peripheral and CNS compartments at the mild cognitive impairment (MCI) stage of Alzheimer's disease (AD). METHODS: A cross-sectional study of patients with clinical and biomarker characteristics consistent with MCI-AD in a discovery cohort, with replication in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Inflammatory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31353852
DOI: 10.1002/acn3.50827

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Key inflammatory pathway activations in the MCI stage of Alzheimer’s diseasePMID 31353852Read ↗

Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized InterventionSemantic proximity Read ↗

Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot StudySemantic proximity Read ↗

Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s diseaseSemantic proximity Read ↗

Tracking the progression of Alzheimer’s disease with peripheral blood monocytesSemantic proximity Read ↗

Identification of conserved proteomic networks in neurodegenerative dementiaSemantic proximity Read ↗

Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer’s disease in mild cognitive impairment patientsSemantic proximity Read ↗

Multimodal single-cell/nucleus RNA-sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer’s diseaseSemantic proximity Read ↗

Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s diseaseSemantic proximity Read ↗

Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer's DiseaseSemantic proximity Read ↗

Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort studySemantic proximity Read ↗

Complement Biomarkers as Predictors of Disease Progression in Alzheimer’s DiseaseSemantic proximity Read ↗

The role of monocytes and macrophages in the progression of Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.